Inhibition of aldose-reductase-2 by a benzofuroxane derivative bf-5m increases the expression of kcne1, kcnq1 in high glucose cultured H9c2 cardiac cells and sudden cardiac death
Inhibition of aldose-reductase-2 by a benzofuroxane derivative bf-5m increases the expression of kcne1, kcnq1 in high glucose cultured H9c2 cardiac cells and sudden cardiac death |
https://doi.org/10.18632/oncotarget.23270
Maria Consiglia Trotta,
Monica Salerno,
Anna Lisa Brigida,
Vincenzo Monda,
Antonietta Messina,
Carmela Fiore,
Roberto Avola,
Renato Bernardini,
Francesco Sessa,
Gabriella Marsala,
Guido N. Zanghì,
Giovanni Messina,
Michele D’Amico,
and Clara Di Filippo
|
17257-17269 |
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile |
https://doi.org/10.18632/oncotarget.24775
Veronika Reidel,
Johanna Kauschinger,
Richard T. Hauch,
Catharina Müller-Thomas,
Niroshan Nadarajah,
Rainer Burgkart,
Burkhard Schmidt,
Dirk Hempel,
Anne Jacob,
Julia Slotta-Huspenina,
Ulrike Höckendorf,
Christian Peschel,
Wolfgang Kern,
Torsten Haferlach,
Katharina S. Götze,
Stefanie Jilg,
and Philipp J. Jost
|
17270-17281 |
Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting |
https://doi.org/10.18632/oncotarget.24629
Neja Samec,
Ivana Jovcevska,
Jure Stojan,
Alja Zottel,
Mirjana Liovic,
Michael P. Myers,
Serge Muyldermans,
Jernej Šribar,
Igor Križaj,
and Radovan Komel
|
17282-17299 |
MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma
MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma |
https://doi.org/10.18632/oncotarget.24644
Lorenzo Nicolè,
Rocco Cappellesso,
Tiziana Sanavia,
Vincenza Guzzardo,
and Ambrogio Fassina
|
17300-17308 |
Characterization of miRNA and their target gene during chicken embryo skeletal muscle development
Characterization of miRNA and their target gene during chicken embryo skeletal muscle development |
https://doi.org/10.18632/oncotarget.22457
Endashaw Jebessa,
Hongjia Ouyang,
Bahareldin Ali Abdalla,
Zhenhui Li,
Auwalu Yusuf Abdullahi,
Qingshen Liu,
Qinghua Nie,
and Xiquan Zhang
|
17309-17324 |
3D laparoscopic surgery: a prospective clinical trial
3D laparoscopic surgery: a prospective clinical trial |
https://doi.org/10.18632/oncotarget.24669
Antonino Agrusa,
Giuseppe Di Buono,
Salvatore Buscemi,
Gaspare Cucinella,
Giorgio Romano,
and Gaspare Gulotta
|
17325-17333 |
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer |
https://doi.org/10.18632/oncotarget.24671
Sandrine M. Caputo,
Mélanie Léone,
Francesca Damiola,
Asa Ehlen,
Aura Carreira,
Pascaline Gaidrat,
Alexandra Martins,
Rita D. Brandão,
Ana Peixoto,
Ana Vega,
Claude Houdayer,
Capucine Delnatte,
Myriam Bronner,
Danièle Muller,
Laurent Castera,
Marine Guillaud-Bataille,
Inge Søkilde,
Nancy Uhrhammer,
Sophie Demontety,
Hélène Tubeuf,
Gaïa Castelain,
French COVAR group collaborators,
Uffe Birk Jensen,
Ambre Petitalot,
Sophie Krieger,
Cédrick Lefol,
Virginie Moncoutier,
Nadia Boutry-Kryza,
Henriette Roed Nielsen,
Olga Sinilnikova,
Dominique Stoppa-Lyonnet,
Amanda B. Spurdle,
Manuel R. Teixeira,
Florence Coulet,
Mads Thomassen,
and Etienne Rouleau
|
17334-17348 |
In silico prediction of targets for anti-angiogenesis and their in vitro evaluation confirm the involvement of SOD3 in angiogenesis
In silico prediction of targets for anti-angiogenesis and their in vitro evaluation confirm the involvement of SOD3 in angiogenesis |
https://doi.org/10.18632/oncotarget.24693
Javier A. García-Vilas,
Ian Morilla,
Anibal Bueno,
Beatriz Martínez-Poveda,
Miguel Ángel Medina,
and Juan A.G. Ranea
|
17349-17367 |
An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients
An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients |
https://doi.org/10.18632/oncotarget.24089
Peng Lin,
Rong-Quan He,
Yi-Wu Dang,
Dong-Yue Wen,
Jie Ma,
Yun He,
Gang Chen,
and Hong Yang
|
17368-17395 |
Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers |
https://doi.org/10.18632/oncotarget.24712
Osamu Soma,
Shingo Hatakeyama,
Teppei Okamoto,
Naoki Fujita,
Teppei Matsumoto,
Yuki Tobisawa,
Tohru Yoneyama,
Hayato Yamamoto,
Takahiro Yoneyama,
Yasuhiro Hashimoto,
Takuya Koie,
Shigeyuki Nakaji,
and Chikara Ohyama
|
17396-17405 |
The role of particulate matters on methylation of IFN-γ and IL-4 promoter genes in pediatric allergic rhinitis
The role of particulate matters on methylation of IFN-γ and IL-4 promoter genes in pediatric allergic rhinitis |
https://doi.org/10.18632/oncotarget.24227
Youjin Li,
Zhe Mu,
Hongyang Wang,
Jinfen Liu,
and Fan Jiang
|
17406-17419 |
Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years
Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years |
https://doi.org/10.18632/oncotarget.24724
Louis Jacob,
Moritz Freyn,
Matthias Kalder,
Konstantinos Dinas,
and Karel Kostev
|
17420-17429 |
Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis
Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis |
https://doi.org/10.18632/oncotarget.24732
Joy Cuenco,
Natascha Wehnert,
Oleg Blyuss,
Anna Kazarian,
Harry J. Whitwell,
Usha Menon,
Anne Dawnay,
Michael P. Manns,
Stephen P. Pereira,
and John F. Timms
|
17430-17442 |
IL-6 influences the polarization of macrophages and the formation and growth of colorectal tumor
IL-6 influences the polarization of macrophages and the formation and growth of colorectal tumor |
https://doi.org/10.18632/oncotarget.24734
Lechuang Chen,
Shuren Wang,
Yu Wang,
Weina Zhang,
Kai Ma,
Chenfei Hu,
Hongxia Zhu,
Shufang Liang,
Mei Liu,
and Ningzhi Xu
|
17443-17454 |
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease |
https://doi.org/10.18632/oncotarget.24736
Marcia Cristina T. dos Santos,
Miguel Arturo Barreto-Sanz,
Bruna Renata S. Correia,
Rosie Bell,
Catherine Widnall,
Luis Tosar Perez,
Caroline Berteau,
Claudia Schulte,
Dieter Scheller,
Daniela Berg,
Walter Maetzler,
Pedro A.F. Galante,
and Andre Nogueira da Costa
|
17455-17465 |
FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer
FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer |
https://doi.org/10.18632/oncotarget.24739
Abdul Khalid Siraj,
Poyil Pratheeshkumar,
Sandeep Kumar Parvathareddy,
Zeeshan Qadri,
Saravanan Thangavel,
Saeeda Ahmed,
Fouad Al-Dayel,
Asma Tulbah,
Dahish Ajarim,
and Khawla S. Al-Kuraya
|
17466-17482 |
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case–control study
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case–control study |
https://doi.org/10.18632/oncotarget.24756
Filomena Morisco,
Silvia Camera,
Maria Guarino,
Raffaella Tortora,
Valentina Cossiga,
Anna Vitiello,
Gabriella Cordone,
Nicola Caporaso,
Giovan Giuseppe Di Costanzo,
and Italian Liver Cancer (ITA.LI.CA) group
|
17483-17490 |
Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients
Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients |
https://doi.org/10.18632/oncotarget.24766
Alfredo Campennì,
Luca Giovanella,
Salvatore Antonio Pignata,
Antonio Vento,
Angela Alibrandi,
Letterio Sturiale,
Riccardo Laudicella,
Alessio Danilo Comis,
Rossella Filice,
Giuseppe Giuffrida,
Maria Elena Stipo,
Salvatore Giovinazzo,
Francesco Trimarchi,
Rosaria Maddalena Ruggeri,
and Sergio Baldari
|
17491-17500 |
BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer
BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer |
https://doi.org/10.18632/oncotarget.24770
Verena Wieser,
Inge Gaugg,
Martina Fleischer,
Giridhar Shivalingaiah,
Soeren Wenzel,
Susanne Sprung,
Sigurd F. Lax,
Alain G. Zeimet,
Heidelinde Fiegl,
and Christian Marth
|
17501-17511 |
The HNF-1β―USP28―Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma
The HNF-1β―USP28―Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma |
https://doi.org/10.18632/oncotarget.24776
Fuminori Ito,
Chiharu Yoshimoto,
Yuki Yamada,
Tamotsu Sudo,
and Hiroshi Kobayashi
|
17512-17522 |
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis |
https://doi.org/10.18632/oncotarget.24778
Antonino Tuttolomondo,
Claudia Colomba,
Danilo Di Bona,
Alessandra Casuccio,
Domenico Di Raimondo,
Giuseppe Clemente,
Valentina Arnao,
Rosaria Pecoraro,
Paolo Ragonese,
Anna Aiello,
Giulia Accardi,
Rosario Maugeri,
Carlo Maida,
Irene Simonetta,
Vittoriano Della Corte,
Domenico Gerardo Iacopino,
Calogero Caruso,
Antonio Cascio,
Antonio Pinto,
and on behalf of KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group
|
17523-17532 |
Risk of sexual transmitted infection following bipolar disorder: a nationwide population-based cohort study
Risk of sexual transmitted infection following bipolar disorder: a nationwide population-based cohort study |
https://doi.org/10.18632/oncotarget.24780
Shyh-Chyang Lee,
Chang-Kuo Hu,
Jeng-Hsiu Hung,
Albert C. Yang,
Shih-Jen Tsai,
Min-Wei Huang,
Li-Yu Hu,
and Cheng-Che Shen
|
17533-17542 |
RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells
RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells |
https://doi.org/10.18632/oncotarget.24784
Marianna Gallo,
Daniela Frezzetti,
Cristin Roma,
Nicoletta Chicchinelli,
Antonio Barbieri,
Claudio Arra,
Giosuè Scognamiglio,
Gerardo Botti,
Antonella De Luca,
and Nicola Normanno
|
17543-17553 |
Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC)
Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC) |
https://doi.org/10.18632/oncotarget.24785
Silvia Vecchiarelli,
Francesco Passiglia,
Armida D’Incecco,
Marianna Gallo,
Antonella De Luca,
Elisa Rossi,
Federica D’Incà,
Gabriele Minuti,
Lorenza Landi,
Chiara Bennati,
Michela Spreafico,
Manolo D’Arcangelo,
Valentina Mazza,
Nicola Normanno,
and Federico Cappuzzo
|
17554-17563 |
Sulforaphane suppresses oral cancer cell migration by regulating cathepsin S expression
Sulforaphane suppresses oral cancer cell migration by regulating cathepsin S expression |
https://doi.org/10.18632/oncotarget.24786
Chang-Tai Chen,
Ming-Ju Hsieh,
Yi-Hsien Hsieh,
Min-Chieh Hsin,
Yi-Ting Chuang,
Shun-Fa Yang,
Jia-Sin Yang,
and Chiao-Wen Lin
|
17564-17575 |
Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients
Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients |
https://doi.org/10.18632/oncotarget.24799
David S. Moura,
Rafael Ramos,
Antonio Fernandez-Serra,
Teresa Serrano,
Julia Cruz,
Ramiro Alvarez-Alegret,
Rosa Ortiz-Duran,
Luis Vicioso,
Maria Luisa Gomez-Dorronsoro,
Xavier Garcia del Muro,
Javier Martinez-Trufero,
Jordi Rubio-Casadevall,
Isabel Sevilla,
Nuria Lainez,
Antonio Gutierrez,
Cesar Serrano,
Maria Lopez-Alvarez,
Nadia Hindi,
Miguel Taron,
José Antonio López-Guerrero,
and Javier Martin-Broto
|
17576-17588 |
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans |
https://doi.org/10.18632/oncotarget.24564
Philip Carter,
Costi Alifrangis,
Biancastella Cereser,
Pramodh Chandrasinghe,
Lisa Del Bel Belluz,
Nina Moderau,
Fotini Poyia,
Lee S. Schwartzberg,
Neha Tabassum,
Jinrui Wen,
Jonathan Krell,
and Justin Stebbing
|
17589-17596 |
Interactions among variants in TXA2R, P2Y12 and GPIIIa are associated with carotid plaque vulnerability in Chinese population
Interactions among variants in TXA2R, P2Y12 and GPIIIa are associated with carotid plaque vulnerability in Chinese population |
https://doi.org/10.18632/oncotarget.24801
Xingyang Yi,
Jing Lin,
Hua Luo,
Ju Zhou,
Qiang Zhou,
Yanfen Wang,
and Chun Wang
|
17597-17607 |
A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies
A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies |
https://doi.org/10.18632/oncotarget.24807
Sandra Rosskopf,
Judith Leitner,
Wolfgang Paster,
Laura T. Morton,
Renate S. Hagedoorn,
Peter Steinberger,
and Mirjam H.M. Heemskerk
|
17608-17619 |
Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells
Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells |
https://doi.org/10.18632/oncotarget.24811
Toshiki Iwai,
Yui Harada,
Hiroshi Saeki,
Eiji Oki,
Yoshihiko Maehara,
and Yoshikazu Yonemitsu
|
17620-17630 |
BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells
BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells |
https://doi.org/10.18632/oncotarget.24815
Erminia Romano,
Nicole Rufo,
Hannelie Korf,
Chantal Mathieu,
Abhishek D. Garg,
and Patrizia Agostinis
|
17631-17644 |
CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells
CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells |
https://doi.org/10.18632/oncotarget.24824
Saya Ito,
Akihisa Ueno,
Takashi Ueda,
Hideo Nakagawa,
Hidefumi Taniguchi,
Naruhiro Kayukawa,
Atsuko Fujihara-Iwata,
Fumiya Hongo,
Koji Okihara,
and Osamu Ukimura
|
17645-17655 |
Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma?
Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma? |
https://doi.org/10.18632/oncotarget.24825
Łukasz Kuźbicki,
Dariusz Lange,
Agata Stanek-Widera,
Agnieszka Glińska,
and Barbara W. Chwirot
|
17656-17663 |
Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy
Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy |
https://doi.org/10.18632/oncotarget.24830
Nobuaki Mamesaya,
Kazushige Wakuda,
Katsuhiro Omae,
Eriko Miyawaki,
Mie Kotake,
Takumi Fujiwara,
Takahisa Kawamura,
Haruki Kobayashi,
Kazuhisa Nakashima,
Shota Omori,
Akira Ono,
Hirotsugu Kenmotsu,
Tateaki Naito,
Haruyasu Murakami,
Keita Mori,
Hideyuki Harada,
Masahiro Endo,
Takashi Nakajima,
and Toshiaki Takahashi
|
17664-17674 |
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies
A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies |
https://doi.org/10.18632/oncotarget.24832
Norbert Vey,
Lionel Karlin,
Sophie Sadot-Lebouvier,
Florence Broussais,
Dominique Berton-Rigaud,
Jérôme Rey,
Aude Charbonnier,
Delphine Marie,
Pascale André,
Carine Paturel,
Robert Zerbib,
Jaafar Bennouna,
Gilles Salles,
and Anthony Gonçalves
|
17675-17688 |
The role of oxidative stress in activity of anticancer thiosemicarbazones
The role of oxidative stress in activity of anticancer thiosemicarbazones |
https://doi.org/10.18632/oncotarget.24844
Katarzyna Malarz,
Anna Mrozek-Wilczkiewicz,
Maciej Serda,
Marta Rejmund,
Jaroslaw Polanski,
and Robert Musiol
|
17689-17710 |
PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer
PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer |
https://doi.org/10.18632/oncotarget.24845
Naoko Ishida,
Motoi Baba,
Yutaka Hatanaka,
Kanako Hagio,
Hiromi Okada,
Kanako C. Hatanaka,
Kenichi Togashi,
Yoshihiro Matsuno,
and Hiroko Yamashita
|
17711-17724 |
The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke
The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke |
https://doi.org/10.18632/oncotarget.24877
Xingyang Yi,
Jing Lin,
Ju Zhou,
Yanfeng Wang,
Ruyue Huang,
and Chun Wang
|
17725-17734 |
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer |
https://doi.org/10.18632/oncotarget.24878
Agnieszka Dansonka-Mieszkowska,
Lukasz M. Szafron,
Joanna Moes-Sosnowska,
Mariusz Kulinczak,
Anna Balcerak,
Bozena Konopka,
Magdalena Kulesza,
Agnieszka Budzilowska,
Martyna Lukasik,
Urszula Piekarska,
Iwona K. Rzepecka,
Joanna Parada,
Renata Zub,
Barbara Pienkowska-Grela,
Radoslaw Madry,
Jan K. Siwicki,
and Jolanta Kupryjanczyk
|
17735-17755 |
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor |
https://doi.org/10.18632/oncotarget.24879
Caroline Vandeputte,
Pashalina Kehagias,
Hakim El Housni,
Lieveke Ameye,
Jean-François Laes,
Christine Desmedt,
Christos Sotiriou,
Amélie Deleporte,
Francesco Puleo,
Karen Geboes,
Thierry Delaunoit,
Gauthier Demolin,
Marc Peeters,
Lionel D’Hondt,
Jos Janssens,
Javier Carrasco,
Raphaël Marechal,
Maria Gomez Galdon,
Pierre Heimann,
Marianne Paesmans,
Patrick Flamen,
and Alain Hendlisz
|
17756-17769 |
Aloe-emodin as drug candidate for cancer therapy
Aloe-emodin as drug candidate for cancer therapy |
https://doi.org/10.18632/oncotarget.24880
Nadire Özenver,
Mohamed Saeed,
Lütfiye Ömür Demirezer,
and Thomas Efferth
|
17770-17796 |
Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent
Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent |
https://doi.org/10.18632/oncotarget.24882
Eleni-Dimitra Papanagnou,
Evangelos Terpos,
Efstathios Kastritis,
Issidora S. Papassideri,
Ourania E. Tsitsilonis,
Meletios A. Dimopoulos,
and Ioannis P. Trougakos
|
17797-17809 |
Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour
Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour |
https://doi.org/10.18632/oncotarget.24891
Marta Smeda,
Anna Kieronska,
Bartosz Proniewski,
Agnieszka Jasztal,
Anna Selmi,
Krystyna Wandzel,
Agnieszka Zakrzewska,
Tomasz Wojcik,
Kamil Przyborowski,
Katarzyna Derszniak,
Marta Stojak,
Dawid Kaczor,
Elzbieta Buczek,
Cezary Watala,
Joanna Wietrzyk,
and Stefan Chlopicki
|
17810-17824 |
Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression
Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression |
https://doi.org/10.18632/oncotarget.24895
Bothina Al-Harbi,
Siti-Fauziah Hendrayani,
Gabriela Silva,
and Abdelilah Aboussekhra
|
17825-17838 |
Structural characterization and in vivo pro-tumor properties of a highly conserved matrikine
Structural characterization and in vivo pro-tumor properties of a highly conserved matrikine |
https://doi.org/10.18632/oncotarget.24894
Jordan Da silva,
Pedro Lameiras,
Abdelilah Beljebbar,
Alexandre Berquand,
Matthieu Villemin,
Laurent Ramont,
Sylvain Dukic,
Jean-Marc Nuzillard,
Michael Molinari,
Mathieu Gautier,
Sylvie Brassart-Pasco,
and Bertrand Brassart
|
17839-17857 |
High levels of circulating endothelial progenitor cells in patients with diabetic retinopathy are positively associated with ARHGAP22 expression
High levels of circulating endothelial progenitor cells in patients with diabetic retinopathy are positively associated with ARHGAP22 expression |
https://doi.org/10.18632/oncotarget.24909
Yu-Chuen Huang,
Wen-Ling Liao,
Jane-Ming Lin,
Ching-Chu Chen,
Shih-Ping Liu,
Shih-Yin Chen,
Yu-Ning Lin,
Yu-Jie Lei,
Huan-Ting Liu,
Yu-Jen Chen,
and Fuu-Jen Tsai
|
17858-17866 |
Advance care planning and outcome in pediatric palliative home care
Advance care planning and outcome in pediatric palliative home care |
https://doi.org/10.18632/oncotarget.24929
Jessica I. Hoell,
Hannah L. Weber,
Stefan Balzer,
Mareike Danneberg,
Gabriele Gagnon,
Laura Trocan,
Arndt Borkhardt,
Gisela Janßen,
and Michaela Kuhlen
|
17867-17875 |
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types |
https://doi.org/10.18632/oncotarget.24947
Prashant D. Tailor,
Sai Karthik Kodeboyina,
Shan Bai,
Nikhil Patel,
Shruti Sharma,
Akshay Ratnani,
John A. Copland,
Jin-Xiong She,
and Ashok Sharma
|
17876-17888 |
Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib
Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib |
https://doi.org/10.18632/oncotarget.24954
Ami B. Patel,
Thoralf Lange,
Anthony D. Pomicter,
Christopher J. Conley,
Christina A. Harrington,
Kimberly R. Reynolds,
Todd W. Kelley,
Thomas O’Hare,
and Michael W. Deininger
|
17889-17894 |
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas |
https://doi.org/10.18632/oncotarget.24860
Francesco Vasuri,
Silvia Fittipaldi,
Vanessa De Pace,
Laura Gramantieri,
Valentina Bertuzzo,
Matteo Cescon,
Antonio D. Pinna,
Michelangelo Fiorentino,
Antonia D’Errico,
and Matteo Ravaioli
|
17895-17905 |
Dose-finding study of oxaliplatin associated to capecitabine-based preoperative chemoradiotherapy in locally advanced rectal cancer
Dose-finding study of oxaliplatin associated to capecitabine-based preoperative chemoradiotherapy in locally advanced rectal cancer |
https://doi.org/10.18632/oncotarget.24665
Gemma Bruera,
Mario Di Staso,
Pierluigi Bonfili,
Antonio Galvano,
Rosa Manetta,
Gino Coletti,
Roberto Vicentini,
Stefano Guadagni,
Corrado Ficorella,
Ernesto Di Cesare,
Antonio Russo,
and Enrico Ricevuto
|
17906-17914 |
Microbiota effects on cancer: from risks to therapies
Microbiota effects on cancer: from risks to therapies |
https://doi.org/10.18632/oncotarget.24681
Domenica Rea,
Giovanni Coppola,
Giuseppe Palma,
Antonio Barbieri,
Antonio Luciano,
Paola Del Prete,
Sabrina Rossetti,
Massimiliano Berretta,
Gaetano Facchini,
Sisto Perdonà,
Maria Caterina Turco,
and Claudio Arra
|
17915-17927 |
Differential role of CXCR3 in inflammation and colorectal cancer
Differential role of CXCR3 in inflammation and colorectal cancer |
https://doi.org/10.18632/oncotarget.24730
Jessicca D. Abron,
Narendra P. Singh,
Angela E. Murphy,
Manoj K. Mishra,
Robert L. Price,
Mitzi Nagarkatti,
Prakash S. Nagarkatti,
and Udai P. Singh
|
17928-17936 |
Phytochemicals as modulators of M1-M2 macrophages in inflammation
Phytochemicals as modulators of M1-M2 macrophages in inflammation |
https://doi.org/10.18632/oncotarget.24788
Uzma Saqib,
Sutripta Sarkar,
Kyoungho Suk,
Owais Mohammad,
Mirza S. Baig,
and Rajkumar Savai
|
17937-17950 |
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach |
https://doi.org/10.18632/oncotarget.24885
Katia Mangano,
Emanuela Mazzon,
Maria Sofia Basile,
Roberto Di Marco,
Placido Bramanti,
Santa Mammana,
Maria Cristina Petralia,
Paolo Fagone,
and Ferdinando Nicoletti
|
17951-17970 |
Immunotherapy in mucosal melanoma: a case report and review of the literature
Immunotherapy in mucosal melanoma: a case report and review of the literature |
https://doi.org/10.18632/oncotarget.24727
Hana Studentova,
Hana Kalabova,
Pavel Koranda,
Karin Chytilova,
Ladislava Kucerova,
Bohuslav Melichar,
and David Vrana
|
17971-17977 |
Correction: Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells
Correction: Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells |
https://doi.org/10.18632/oncotarget.25078
Xin-Xing Zhu,
Ya-Wei Yan,
Demeng Chen,
Chun-Zhi Ai,
Xifeng Lu,
Shan-Shan Xu,
Shan Jiang,
Gen-Shen Zhong,
Dong-Bao Chen,
and Yi-Zhou Jiang
|
17978-17978 |
Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy
Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy |
https://doi.org/10.18632/oncotarget.25079
Wei Shi,
Yanxue Yin,
Yao Wang,
Bo Zhang,
Pei Tan,
Ting Jiang,
Heng Mei,
Jun Deng,
Huafang Wang,
Tao Guo,
Zhiqing Pang,
and Yu Hu
|
17979-17979 |